Publikasi

Microglia Activity in the Brain Drives Infantile Amnesi...

Immune cells in the brain may explain why infants across species fail to retain ...

HRV Pharma and Haleos Labs forge unique strategic CDMO ...

HRV Global Life Sciences (HRV Pharma), India’s first integrated Virtual API and...

Nasal Passage Cell Response to Common Cold Virus Determ...

Preclinical study demonstrates how the cells in our noses defend us from the com...

What’s the most-used emoji in medical records?

The use of emojis in medical records appears to be on the upswing, according to ...

GSK to Acquire Rapt for $2.2B, Adding Food Allergy Cand...

Ozureprubart is designed for every-12-week dosing, a less frequent dosage than t...

Key Strategies for dsRNA Control and Quantitation in Em...

As mRNA based therapeutics move beyond the early vaccine successes to encompass ...

Astellas Takes Aim at XLMTM Again, Now with MyoAAV Caps...

The therapy, which Kate calls KT430, is being developed by Astellas through an e...

NYC-Based Excelsior Looks to Blur Boundary Between Disc...

The New York-based company enables AI-guided optimization through a molecule’s l...

Chhattisgarh seeks pharma investment with dedicated pha...

Chhattisgarh is stepping up efforts to position itself as a leading pharmaceuti...

DeepHow introduces PharmaCloud for pharmaceutical manuf...

The new solution is intended for pharmaceutical and medical device manufacturers...

iRegene receives FDA RMAT designation for NouvNeu001 to...

This marks the first instance of an allogeneic induced pluripotent stem cell (iP...

Public Health Transformation Summit 2026 reframes how I...

Recognised by the Ministry of Electronics and Information Technology (MeitY), G...

Manthan 2026 concludes successfully, advancing dialogue...

Manthan 2026, a Research & Development Leadership Symposium, concluded successf...

Syngene International extends long-term research collab...

Syngene International, a global contract research, development, and manufacturi...

FDA grants Novartis’ ianalumab breakthrough therapy sta...

Ianalumab is a fully human monoclonal antibody that targets B-cells and inhibits...

AstraZeneca to acquire China rights for AbelZeta’s CAR-...

The acquisition gives AstraZeneca full global control over the development, manu...